The aim is to evaluate the survival rates of children with relapsed Wilms tumour after risk stratification and high-dose chemotherapy.
Conducted a trial on children with relapsed Wilms tumour
Implemented risk stratification techniques
Administered high-dose chemotherapy in treatment protocol
Survival rates improved compared to historical data
Indicates effectiveness of risk stratification and high-dose chemotherapy
Abstract
Survival rates following risk stratification including M + ASCT are higher than historical observations for similar high-risk groups that did not include high-dose chemotherapy.